
Fundamentals and Future Trends of 3D Printing in Drug Delivery
- 1st Edition - November 20, 2024
- Imprint: Academic Press
- Editors: Dimitrios A. Lamprou, Dimitrios G. Fatouros
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 4 5 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 4 6 - 4
Fundamentals and Future Trends of 3D Printing in Drug Delivery provides readers with all needed information for their journey from ideation to approval of innovative drug delivery… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteFundamentals and Future Trends of 3D Printing in Drug Delivery provides readers with all needed information for their journey from ideation to approval of innovative drug delivery devices produced through additive manufacturing.
This book provides an in-depth discussion on key factors affecting the printing process such as different printer technologies, materials selection, resolutions, temperatures and speeds. Dedicated chapters include specific drug delivery devices in the form of oral solid dosage, implants, catheters and vascular grafts, and microneedles. The prospects of 3D printing associated with personalized medicine are covered in a full chapter.
Fundamentals and Future Trends of 3D Printing in Drug Delivery is the perfect reference for any researcher or professional embarking on a 3D printing process for drug delivery devices. The regulatory aspects included are of particular interest to companies entering this promising market.
- Includes discussion on key parameters of the printing process like materials selection, temperatures, printing technologies, resolutions, and speeds
- 3D printed drug delivery methods covered include oral solid dosage, implants, catheters and vascular grafts, and microneedles
- Covers the potential of 3D printed drug delivery for personalized medicine
Researchers in Industry and Academia working in drug delivery and medical implants, in general, and specifically using additive manufacturing technologies. Undergraduate and Postgraduate (e.g., Masters, Ph.D.) students in Pharmacy, Pharmaceutical Sciences, and Pharmaceutical Biotechnology. Regulatory bodies. Pharmaceutical, biopharmaceutical, additive manufacturing, and biofabrication industries. The book can be used from most pharmacy, pharmaceutical sciences, and pharmaceutical technologies courses for undergraduate students and from a variety of Master courses worldwide (e.g., Additive Manufacturing, Industrial Pharmaceutics, Drug Delivery, and Biofabrication)
2. 3D printing Technologies for pharmaceutical applications
3. Polymeric biomaterials for 3D printing
4. Design Optimization and Finite Element Analysis of 3D Printed Systems
5. 3D Printing in Personalized Medicine
6. 3D Printing of pharmaceutical oral solid dosage forms
7. 3D Printed personalized long-acting pharmaceutical Implants
8. Development of 3D printed drug loaded catheters & vascular grafts
9. 3D Printed Microneedle Patches for Painless Drug Delivery
10. 3D Printed therapeutic scaffolds for wound healing applications
11. 3D Printing in Oncology
12. 3D Printed gynecological implants
13. 3D printing in preclinical evaluation
14. 4D Printed therapeutic systems
15. Additive manufacturing and AI
16. Regulatory in 3D printing systems in healthcare
- Edition: 1
- Published: November 20, 2024
- No. of pages (Paperback): 354
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443236457
- eBook ISBN: 9780443236464
DL
Dimitrios A. Lamprou
Professor Dimitrios A. Lamprou (Ph.D. MBA) is the Chair of Biofabrication and Advanced Manufacturing, the Director of Internationalisation, and the Director at MSc Industrial Pharmaceutics at Queen's University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and Visiting Professor in several International Institutions. Dimitrios, is the author of more than 170 peer-reviewed publications, has over 450 conference abstracts, and has given over 200 Invited Talks in institutions and conferences across the world. Dimitrios, has also been named in the Stanford University's list of World's Top 2% Scientists, for several consecutive years, for his research in Pharmaceutics and Biomedical Engineering.
DF